Karl M. Kilgore, PhD, designs and develops health economics and outcomes studies, descriptive and analytic epidemiology studies, outcomes-based marketing programs, and disease registries.

With a focus on outcomes, he provides clients with actionable insights and analysis.

Prior to joining Avalere, he was project lead, Health Economics and Outcomes Researcher, at Inovalon. In this capacity, he focused his work on the dual eligible population, the impact of the ACA on healthcare delivery and outcomes, and how social, behavioral, and genetic factors interact to impact population health. Prior to joining Inovalon, he was vice president of Research and Outcomes for Cetus Group, a contract research organization serving the pharmaceutical and medical device industries. In addition to his research experience, he brings to bear his extensive data analysis, programming, and data warehouse design expertise.

He received his PhD in psychology from the University of Chicago with concentration in epidemiology, statistical analysis, and research methods.

Authored Content

Avalere Health partnered with the Academy of Nutrition and Dietetics and other stakeholders for the Malnutrition Quality Improvement Initiative (MQii) designed to advance evidence-based, high-quality, and patient-driven care for hospitalized older adults who are malnourished or at risk for malnutrition.

On Saturday, December 7, Karl Kilgore discussed “Medicare Patients Receiving Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma: A First Real-World Look at Patient Characteristics, Healthcare Utilization and Costs” during a press briefing at the American Society of Hematology’s Annual Meeting.

Avalere experts recently presented “Risk Adjusting Medicare Advantage Plan Performance Measures for Social Determinants of Health: Are Dual Eligibility and Disability Status Enough?” at the Academy Health 2019 Annual Research Meeting.

New Avalere study entitled “Using Aggregate Data to Proxy Individual-Level Socioeconomic Characteristics in Research on Medication Adherence: 9-Digit ZIP Code vs. Census Block Group” selected for the AMCP Foundation Best Poster Award at AMCP Nexus 2018.

Our analysis finds there will be winners and losers at the plan level under the new models.